Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6107231

O=C(Nc1ccc(Cl)cn1)c1c(F)cccc1NC(=O)C1CCNCC1.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ CDK2 P24941 3/20 0.46
▸ CDK4 P11802 1/20 0.46
▸ CDK5 Q00535 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.45
▸ F10 P00742 4/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ CCNA2 P20248 2/20 0.43
▸ SCN9A Q15858 1/20 0.41
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CDK1 P06493 1/20 0.40
▸ CCNB1 P14635 1/20 0.40
▸ CCNA1 P78396 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6108176 0.93 CDK2 (0.51) BRD4SMN1; SMN2NPC1RAB9AALDH1A1
Trifluoroacetic Acid SCHEMBL6107727 0.87 F10 (0.54) SMN1; SMN2NPC1RAB9ATSHRTDP1
Trifluoroacetic Acid SCHEMBL6769487 0.86 F10 (0.47) BRD4SMN1; SMN2NPC1RAB9AALDH1A1
Trifluoroacetic Acid SCHEMBL6107944 0.84 F10 (0.55) BRD4SMN1; SMN2TSHRTDP1F10
Trifluoroacetic Acid SCHEMBL6105845 0.84 F10 (0.50) BRD4SMN1; SMN2NPC1RAB9AALDH1A1
Trifluoroacetic Acid SCHEMBL6107641 0.83 F10 (0.64) F10
Trifluoroacetic Acid SCHEMBL6108073 0.83 F10 (0.56) BRD4SMN1; SMN2NPC1RAB9AALDH1A1
Trifluoroacetic Acid SCHEMBL6107517 0.83 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AALDH1A1PKM
Trifluoroacetic Acid SCHEMBL6774077 0.82 F10 (0.52) SMN1; SMN2TSHRTDP1F10
Trifluoroacetic Acid SCHEMBL6106676 0.80 F10 (0.57) SMN1; SMN2RAB9ATSHRF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7129245-B2 Anticoagulants which act selectively on factor Xa; fast acting; oral; do not interfere with lysis of blood clots ELI LILLY AND COMPANY (US) 2006-10-31 — — US disclosed
US-20050282862-A1 Aromatic amides BEIGHT DOUGLAS W 2005-12-22 — — US disclosed
EP-1140903-B1 AROMATIC AMIDES LILLY CO ELI (US) 2004-08-04 — — EP disclosed
US-6759414-B2 ANTICOAGULANTS WHICH ACT SELECTIVELY ON FACTOR XA; FAST ACTING; ORAL; DO NOT INTERFERE WITH LYSIS OF BLOOD CLOTS ELI LILLY AND COMPANY 2004-07-06 — — US disclosed
US-20040029874-A1 Aromatic amides BEIGHT DOUGLAS WADE (US) 2004-02-12 — — US disclosed
US-6635657-B1 Pyridine derivatives; anticoagulants ELI LILLY AND COMPANY 2003-10-21 — — US disclosed
EP-1140903-A1 AROMATIC AMIDES ELI LILLY AND COMPANY (US) 2001-10-10 — — EP disclosed
WO-2000039118-A1 AROMATIC AMIDES ELI LILLY AND COMPANY (US) 2000-07-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040029874-A1 Aromatic amides F11, F12, F5 BRD4 2143/4885SMN1; SMN2 3975/4885NPC1 1659/4885
US-20050282862-A1 Aromatic amides F11, F12, F5 BRD4 2143/4885SMN1; SMN2 3975/4885NPC1 1659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback